Asia Pacific viscosupplementation Market is predicted to expand rapidly from 2022 to 2030

The market for viscosupplementation equipment is expected to reach US$ 1.98 Billion in 2022. According to thorough market research, the worldwide Viscosupplementation Market is expected to grow at a CAGR of 4.8% from current levels to reach a market value of US$ 2.89 Billion by 2030.

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19. As per the UN, by 2050, those aged 60 and above will account for over 20% of the global population. In other words, the UN says that by 2050 around 130 Million people will contract osteoarthritis. These numbers point towards growth in the viscosupplementation market in the forecast period.

Joint lubrication therapy is a medical treatment that involves injecting a gel-like substance called hyaluronic acid into a joint affected by osteoarthritis. Hyaluronic acid is a natural component of synovial fluid, the lubricating fluid that cushions and protects the joints. In osteoarthritis, the amount and quality of hyaluronic acid in the synovial fluid is reduced, leading to pain, stiffness, and decreased mobility.

Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Covid-19 Pandemic: Viscosupplementation Market Players Consolidating their Position The ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.

Top Key Players Covered-

• Sanofi S.A.
• Zimmer Biomet Holdings Inc.
• Bioventus LLC
• Anika Therapeutics Inc.
• Fidia Farmaceutici S.p.A.
• Ferring B.V.
• Seikagaku Corporation
• Chugai Pharmaceutical Co., Ltd.
• OrthogenRx Inc.
• Mylan N.V.

Key Takeaways of Viscosupplementation Market Study

• Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
• Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
• North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-9509

New Product Development to be the TorchbearerThe market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

• Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
• Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
• Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Key Segments of Viscosupplementation Industry Survey

Viscosupplementation Market by Product:

• Single Injection Viscosupplementation
• Three Injection Viscosupplementation
• Five Injection Viscosupplementation

Use promo code ->> FMITODAY to get a flat 20% discount

Viscosupplementation Market by Application:

• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Others

Viscosupplementation Market by End User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Retail Pharmacies
• Online Sales

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The post Asia Pacific viscosupplementation Market is predicted to expand rapidly from 2022 to 2030 appeared first on Future Market Insights.